LAUREN CURRY: Open Payments
NPI 1598219560 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,188 in 60 payments from 15 companies in 2025. Trend: 2023 $1,356 · 2024 $1,095 · 2025 $1,188
Food & beverage: $964Education: $224
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $190 |
| ABBVIE INC. | 13 | $182 |
| GENZYME CORPORATION | 9 | $180 |
| Lilly USA, LLC | 9 | $93 |
| LEO Pharma Inc. | 4 | $89 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $85 |
| UCB, Inc. | 3 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Amgen Inc. | 2 | $41 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, TALTZ, RINVOQ, Bimzelx, Sotyktu, ANZUPGO.
Industry payments across KY — which companies pay providers there.
